Literature DB >> 15362036

ClC-2 chloride secretion mediates prostaglandin-induced recovery of barrier function in ischemia-injured porcine ileum.

Adam J Moeser1, Melissa M Haskell, Donnie E Shifflett, Dianne Little, Bruce D Schultz, Anthony T Blikslager.   

Abstract

BACKGROUND & AIMS: Ischemia results in the breakdown of the intestinal barrier, predisposing patients to sepsis and multiple organ failure. Prostaglandins play a critical role in mediating recovery of barrier function in ischemia-injured intestine through a mechanism involving stimulation of Cl - secretion. In the present study, we investigated the contributory role of individual Cl - channels in the recovery of barrier function in ischemia-injured porcine ileum.
METHODS: Ischemia-injured porcine ileal mucosa was mounted in Ussing chambers. Short-circuit current (Isc) and transepithelial resistance (TER) were measured in response to prostaglandin E 2 (PGE 2 ) and pharmacologic inhibitors of epithelial Cl - channels. Immunoassays were used to assess the expression and localization of ion channels.
RESULTS: Application of PGE 2 to ischemia-injured ileal mucosa stimulated increases in Isc, an indicator of Cl - secretion, that was followed by marked increases in TER, an indicator of barrier function recovery. In vitro studies revealed that although PGE 2 induced Cl - secretion via at least 3 distinct secretory pathways, recovery of barrier function was initiated by Cl - secretion via ClC-2 Cl - channels co-expressed with occludin and localized to tight junctions within restituting epithelium. Intravenous administration of furosemide to pigs subjected to 1 hour of ileal ischemia impaired recovery of barrier function, as evidenced by decreased TER and increased mucosal-to-serosal 3 H-mannitol flux after a 2-hour reperfusion/recovery period, confirming an important role for Cl - secretory pathways in vivo.
CONCLUSIONS: ClC-2-mediated intestinal Cl - secretion restores TER in ischemia-injured intestine. These data may provide the basis for targeted pharmacologic therapy for diseases associated with impaired barrier function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362036     DOI: 10.1053/j.gastro.2004.06.004

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  Clcn2 encodes the hyperpolarization-activated chloride channel in the ducts of mouse salivary glands.

Authors:  Victor G Romanenko; Tetsuji Nakamoto; Marcelo A Catalán; Mireya Gonzalez-Begne; George J Schwartz; Yasna Jaramillo; Francisco V Sepúlveda; Carlos D Figueroa; James E Melvin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-18       Impact factor: 4.052

Review 2.  Equine Intestinal Mucosal Pathobiology.

Authors:  Anthony Blikslager; Liara Gonzalez
Journal:  Annu Rev Anim Biosci       Date:  2017-11-16       Impact factor: 8.923

Review 3.  ClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic target.

Authors:  Younggeon Jin; Anthony T Blikslager
Journal:  Tissue Barriers       Date:  2015-11-13

4.  Lubiprostone stimulates secretion from tracheal submucosal glands of sheep, pigs, and humans.

Authors:  N S Joo; J J Wine; A W Cuthbert
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-02-20       Impact factor: 5.464

5.  Lubiprostone protects esophageal mucosa from acid injury in porcine esophagus.

Authors:  Leandi Krüger; Tiffany A Pridgen; Ellie R Taylor; Katherine S Garman; Anthony T Blikslager
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-18       Impact factor: 4.052

6.  Knockout of ClC-2 reveals critical functions of adherens junctions in colonic homeostasis and tumorigenicity.

Authors:  Younggeon Jin; Dina Ibrahim; Scott T Magness; Anthony T Blikslager
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-10-04       Impact factor: 4.052

7.  Gastro protective properties of the novel prostone SPI-8811 against acid-injured porcine mucosa.

Authors:  Meghali Nighot; Adam Moeser; Ryuji Ueno; Anthony Blikslager
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

8.  Lipopolysaccharide activates innate immune responses in murine intestinal myofibroblasts through multiple signaling pathways.

Authors:  Kristen L W Walton; Lisa Holt; R Balfour Sartor
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-08       Impact factor: 4.052

9.  Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine.

Authors:  Adam-J Moeser; Prashant-K Nighot; Birgit Roerig; Ryuji Ueno; Anthony-T Blikslager
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

10.  Lubiprostone stimulates duodenal bicarbonate secretion in rats.

Authors:  Misa Mizumori; Yasutada Akiba; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2009-08-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.